Table 4.
Overall Survival | Progression Free Survival | |||||
---|---|---|---|---|---|---|
HR | 95%Cl | p | HR | 95%Cl | p | |
Age ≥ 65 | 3.19 | 2.03–5.01 | 0.001 | 3.17 | 2.04–4.92 | 0.001 |
Sex | 0.79 | 0.53–1.18 | 0.250 | 0.84 | 0.56–1.25 | 0.384 |
ECOG > 1 | 1.97 | 1.69–2.31 | 0.001 | 1.94 | 1.65–2.27 | 0.001 |
LDH | 1.49 | 0.99–2.25 | 0.053 | 1.52 | 1.02–2.28 | 0.038 |
Bone marrow involvement | 3.2 | 2.05–4.98 | 0.001 | 3.04 | 1.96–4.72 | 0.001 |
Extranodal Disease | 1.61 | 1.07–2.43 | 0.023 | 1.42 | 0.95–2.12 | 0.085 |
Stage (IIIA-IVB) | 4.37 | 2.86–6.69 | 0.001 | 4.07 | 2.68–6.18 | 0.001 |
IPI(low- high) | 4.83 | 3.17–7.36 | 0.001 | 4.52 | 3– 6.82 | 0.001 |
CONUT score | 1.23 | 1.15–1.31 | 0.001 | 1.24 | 1.15–1.33 | 0.001 |